Hepatitis C

IDWeek 2021: Young people who inject drugs can be cured of hepatitis C virus infection, according to 2 new studies.

The American College of Physicians urges clinicians to make sure adult patients, especially the most vulnerable, are protected against preventable diseases as COVID spreads and flu is imminent.

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis is increasing and early detection is critical. Brush up on basics with our slides.

HCV is now diagnosed in millennials at about the same rate as in baby boomers; CDC responds with a recommendation for HCV screening in all adults aged ≥18 years.

Patients who received an HCV-positive liver for transplantation and were later treated performed as well in recovery as those who did not, a recent study suggests.

All adults starting at age 18 should be screened for hepatitis C, according to newly released recommendations from the US Preventive Services Task Force.

Rates of STIs among persons aged ≥60 years are increasing faster than among the general population. Can you speculate as to why?

Point of care HCV testing offers the promise of more widespread testing and more effective linkage to care. Find out what you know--and need to know.

Sexually transmitted disease spread, emerging organisms, antimicrobial resistance, and other ID topics from 2019 make up this Patient Care final challenge.

Millennials have quickly become the population predominantly affected by the HCV epidemic. A new study shines startling light.

Combined cases of 3 sexually transmitted diseases reached an all-time high in the US in 2018. Which 3? It's a test of your STD IQ.

Antibiotic treatment for H. pylori is in trouble; antibiotic-resistant E. coli may not be caused by food. Plus more important research ICYMI, at-a-glance.

A mobile compendium of hepatology assessment tools, an app to help select the right treatment regimen, and 3 more liver apps for primary care.

When is liver transplant curative? What is the best management option for esophageal varices? And, is hepatorenal failure to blame here?  Test your hepatic management know-how.

Sample: True or false? Most new hepatitis C virus infections occur among people who inject drugs. Plus 4 more questions on hepatitis C and injection drug use. 

Nonmedical use of oral prescription opioids overlaps with and fuels widespread HIV and HCV infections and serves as a gateway to other injection drugs.

Vaccines against herpes and chlamydia show promise but sexual health awareness in the US leaves a lot to be desired. The research explains.

Help keep patients with diabetes healthy this flu season with a few of these quick reminders on vaccination, medication, comorbidities, and more. 

When it comes to flu vaccination, nearly 50% of US adults don’t know the benefits. Are your patients among them?

How prevalent is use of antibiotics without a prescription? Why do patients hesitate to be vaccinated? Plus, 3 more questions on ID research that may affect primary care.

CDC's TB screening guidelines for healthcare professionals were updated in May 2019. What changed? Protect yourself, colleagues, and your patients with this short quiz.

Is the expanding paradigm shift toward HCV treatment in primary care effective? Or, should it be left to specialists? Two recent studies shed light.

With the start of peak tick season, check here to spot some of the latest developments in diagnosis and treatment of Lyme disease.

Current research on Lyme disease detection, treatment, and residual effects is the topic of this short catch-up quiz.

How prevalent is use of antibiotics without a prescription? How effective is HCV treatment in people who inject drugs? See snapshots of these study results and 4 more.

How much do you know about the different HCV genotypes and how they impact treatment? Take our quick, 8-question quiz to find out. 

Antibiotic-resistant Neisseria gonorrhea is an international threat. Find out what you know about current first-line treatment in just a few minutes.

Parkinson disease may join the list of extrahepatic complications associated with HCV infection, according to a new study in JAMA Neurology.

Isoniazid resistance in TB may be prevented and even reversed by a small newly identified molecule called C10, according to a recent study.

Approximately two-thirds of persons infected with chronic hepatitis C virus experience nonliver manifestations of the disease. Do you know what to look for?